WIPO trademark

RAGWIZAX

RegisteredWIPOClass 5Class 42Class 44

"RAGWIZAX" is a trademark owned by ALK-Abelló A/S, filed at the WIPO on May 29, 2020. It is registered and covers classes 5, 42 and 44.

View ALK-Abelló A/S portfolioGet this data via the API
RAGWIZAX
Trademark as filed with the WIPO
Status
Registered
Filed
May 29, 2020
Registered
Not yet
Expires
May 29, 2030
Application no.
Not recorded
Registration no.
1569595
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
3 classes
Ownership

Who owns RAGWIZAX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

ALK-Abelló A/S

Denmark

191 trademarks in the portfolioView company

Representative

Patrade A/S

Patrade A/S

Goods and services

What the mark covers

The products and services RAGWIZAX is filed for, grouped by Nice class.

  • Pharmaceutical and veterinary preparations, including pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing materials for medical use; pharmaceutical preparations in the form of injectable pharmaceuticals.

  • Scientific, technological, medical and pharmacological research services and design relating thereto; scientific and medical research laboratory services, clinical trials.

  • Medical services and medical healthcare services; medical consulting services, including counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases, also electronically or digitally, eg through a website; providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases, also electronically or digitally, eg through a website; medical diagnostic services.

FAQ

About RAGWIZAX

Who owns the trademark "RAGWIZAX"?

The WIPO trademark "RAGWIZAX" is owned by ALK-Abelló A/S.

What is the status of "RAGWIZAX"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RAGWIZAX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_c2fcf00b-8451-4d95-8673-03d81f9d6b99
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_c2fcf00b-8451-4d95-8673-03d81f9d6b99",
  "object": "trademark",
  "mark_text": "RAGWIZAX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2020-05-29",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "ALK-Abelló A/S",
      "entity_id": "ent_019eb6f7-d7a6-7420-874f-900c24eb0227"
    }
  ]
}